MedPath

Effect of Gluten Free Diet in Patients With Burning Mouth Syndrome

Not Applicable
Conditions
Burning Mouth Syndrome
Registration Number
NCT01867151
Lead Sponsor
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Brief Summary

Gluten free diet (GFD) is now being tested in patients affected by schizophrenia, autism and multiple sclerosis, making GFD a possible therapeutic weapon not only for celiac disease or gluten sensitivity. In this protocol we investigate the effect of GFD in patients affected by burning mouth syndrome (BMS), a disease of unknown origin characterized by oral and especially tongue burning sensation, deeply decreasing the quality of life of patients

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
40
Inclusion Criteria

-Primary BMS

Exclusion Criteria
  • Celiac Disease
  • Psychiatric Disorders
  • intestinal autoimmune diseases
  • Ongoing cancer

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
oral pain28 days

oral pain will be evaluated by means of visual analogue scales

Secondary Outcome Measures
NameTimeMethod
Quality of Life28 days

quality of life of patients with BMS will be evaluated by means of SF36 questionnaire

Trial Locations

Locations (1)

Fondazione IRCCS Ca' Granda

🇮🇹

Milano, Italy

Fondazione IRCCS Ca' Granda
🇮🇹Milano, Italy

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.